MESSA, LORENZO

MESSA, LORENZO  

Dipartimento di Medicina Molecolare - DMM  

Mostra records
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.073 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
4th European Seminars in Virology on Oncogenic and Oncolytic Viruses, in Bertinoro (Bologna), Italy 2017 REALE, ALBERTOMESSA, LORENZOVITIELLO, ADRIANALOREGIAN, ARIANNAPALU', GIORGIO JOURNAL OF CELLULAR PHYSIOLOGY - -
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth 2020 Celegato M.Messa L.Mercorelli B.Bertagnin C.Palu G.Loregian A. + CANCER LETTERS - -
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells 2018 Messa, LorenzoCelegato, MartaBertagnin, ChiaraMercorelli, BeatriceNannetti, GiulioPalù, GiorgioLoregian, Arianna SCIENTIFIC REPORTS - -
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin 2016 PARISI, SAVERIOLOREGIAN, ARIANNAANDREIS, SAMANTHANANNETTI, GIULIOBASSO, MONICADAL BELLO, FEDERICOMESSA, LORENZOCattelan, Anna MariaPALU', GIORGIO + INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES - -
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma 2017 NANNETTI, GIULIOMESSA, LORENZOCELEGATO, MARTAPAGNI, SILVANABASSO, MONICAParisi, Saverio G.PALU', GIORGIOLOREGIAN, ARIANNA JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS - -
HPV-induced cancers: preclinical therapeutic advancements 2022 Messa L.Loregian A. EXPERT OPINION ON INVESTIGATIONAL DRUGS - -
HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys 2018 Peta, ElektraSinigaglia, AlessandroMasi, GiuliaDi Camillo, BarbaraGrassi, AngelaTrevisan, MartaMessa, LorenzoLoregian, AriannaPalù, GiorgioBarzon, Luisa + ONCOGENE - -
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells 2022 Celegato M.Messa L.Bertagnin C.Mercorelli B.Loregian A. CANCERS - -
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib 2021 Messa L.Celegato M.Bertagnin C.Mercorelli B.Alvisi G.Palu G.Loregian A. + CANCERS - -
The isoquinoline alkaloid berberine inhibits human cytomegalovirus replication by interfering with the viral Immediate Early-2 (IE2) protein transactivating activity 2019 Mercorelli, BeatriceMessa, LorenzoPalù, GiorgioGribaudo, GiorgioLoregian, Arianna + ANTIVIRAL RESEARCH - -